It starts with a 2013 paper from the Mayo Clinic and David Sinclair’s lab. A humble flavonoid found in chamomile tea and parsley was shown to inhibit CD38 — the primary enzyme that destroys NAD+ as we age. That flavonoid is apigenin. A decade later, a 2026 analysis of 8,125 adults identified apigenin as one of just five dietary antioxidants most predictive of slower biological aging. Here’s what the evidence actually says.
Evidence Tier: 🥈 Silver
⚖️ At a Glance: Pros & Cons
⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking any supplement. The information below is for education only.
✅ Pros (What the Evidence Supports)
- Strongest benefit: A 2026 NHANES analysis of 8,125 adults identified apigenin as one of five dietary antioxidants that best predict slower biological aging — alongside magnesium, zinc, vitamin E, and daidzein.
- NAD+ preservation: Apigenin inhibits CD38, the main enzyme that breaks down NAD+ — the same mechanism targeted by expensive NAD+ precursors like NMN and NR.
- Cellular senescence: Multiple 2026 studies show apigenin reduces senescent cells and suppresses the SASP (the inflammatory molecules senescent cells secrete that damage surrounding tissue).
- Safety: Apigenin is widely consumed in chamomile tea, parsley, and celery. It has a long dietary history and a strong safety profile at supplemental doses (50-100 mg/day).
❌ Cons (What the Evidence Doesn’t Support or Warns About)
- Biggest limitation: Almost all longevity evidence comes from cells, animals, and epidemiological data. We have zero randomized controlled trials testing whether apigenin extends human lifespan or healthspan.
- Poor bioavailability: Apigenin has notoriously low water solubility and absorption. Standard oral supplements may deliver only a fraction of the dose to tissues. Liposomal formulations may help but are unproven.
- No standardized dosing: Studies use wildly different doses (from 10 mg to 100 mg/kg in animals). The optimal human dose for longevity is unknown.
- Who should avoid: Pregnant women (hormonal effects), anyone on blood thinners (mild antiplatelet activity), and those on sedatives (apigenin enhances GABA, amplifying drowsiness).
What Is Apigenin?
Apigenin is a natural flavonoid — a type of plant compound found in many fruits, vegetables, and herbs. It belongs to the flavone subclass, which gives it a distinctive chemical structure (three rings with hydroxyl groups) that makes it both a strong antioxidant and a versatile signaling molecule.
The richest dietary sources are:
- Chamomile tea — the most concentrated common source (roughly 2-5 mg per cup)
- Parsley — especially dried parsley, which can contain up to 45 mg per gram
- Celery — stems and leaves both contain apigenin
- Onions, oranges, and thyme — smaller but meaningful amounts
- Chamomile extract supplements — typically standardized to 1.2% apigenin (a 500 mg extract yields ~6 mg apigenin)
In the longevity world, apigenin gained attention because of a single mechanism: it inhibits CD38, an enzyme that consumes NAD+ (nicotinamide adenine dinucleotide) — a molecule essential for cellular energy and repair that declines dramatically with age.
How It Works: The CD38-NAD+ Connection
To understand why apigenin matters for aging, you need to understand NAD+ and CD38:
- NAD+ is a coenzyme found in every cell. It’s required for energy production (metabolism), DNA repair, and the activity of sirtuins — proteins often called “longevity genes” because they regulate aging pathways. NAD+ levels drop by roughly 50% between ages 40 and 60.
- CD38 is an enzyme on the surface of immune cells that breaks down NAD+. As we age, CD38 levels increase dramatically — driven by senescent cells and chronic inflammation. More CD38 means less NAD+, which means less sirtuin activity.
In 2013, a landmark paper from the Mayo Clinic (with David Sinclair as co-author) identified apigenin as a CD38 inhibitor. When they gave apigenin to obese mice, NAD+ levels rose, protein acetylation decreased (a sign of sirtuin activation), and metabolic health improved — lower blood sugar, better lipid profiles, less fatty liver. The effect was similar to what you’d expect from expensive NAD+ precursors like nicotinamide riboside (NR) or NMN, but through a different mechanism: instead of providing more NAD+ building blocks, apigenin prevents NAD+ from being destroyed.
This “plug the drain” approach is complementary to NAD+ precursor supplements. Some researchers argue it may be more physiologically relevant, since the age-related NAD+ decline is driven more by increased CD38 consumption than by decreased NAD+ production.
However, a 2025 study added nuance: apigenin also has CD38-independent anti-inflammatory effects through NLRP3 inflammasome inhibition. In other words, apigenin does more than just inhibit CD38 — it hits multiple aging-relevant pathways simultaneously.
The Longevity Connection
🥈 Slower Biological Aging (Human Data)
The strongest human evidence comes from a 2026 NHANES analysis published in Experimental Gerontology (Zhang et al., PMID: 42119652). Researchers used machine learning (XGBoost) on dietary data from 8,125 U.S. adults to identify which antioxidants best predicted biological age — measured by both the Klemera-Doubal Method (KDM) and Phenotypic Age (PhenoAge). Apigenin emerged as one of five core antioxidants alongside daidzein, magnesium, zinc, and vitamin E. Higher apigenin intake was associated with significantly lower risk of accelerated biological aging, and the association held across sex and age subgroups. The model achieved AUC scores of 0.931 (KDM) and 0.906 (PhenoAge) — excellent predictive performance.
🥈 NAD+ Preservation (Preclinical)
The Escande et al. 2013 study (PMID: 23172919) remains the foundational paper. Apigenin was shown to be a direct CD38 inhibitor. In obese mice, apigenin increased NAD+ levels, activated sirtuins, and improved glucose and lipid metabolism. A 2024 review in Frontiers in Nutrition (Kramer & Johnson, PMID: 38476603) from Tally Health researchers connected these dots to sleep — dietary apigenin intake correlates with sleep quality in large human cohorts, likely through combined effects on GABA receptors and NAD+-dependent circadian pathways.
🥈 Cellular Senescence Reduction (Preclinical, 2026)
Three 2026 studies converge on apigenin’s anti-senescence effects:
- Macrophage SASP inhibition (Ni et al., PMID: 42534541): Apigenin blocks DOT1L, an enzyme that enables senescent immune cells to pump out inflammatory signals (the SASP). In cell culture, apigenin reduced senescence markers and boosted anti-inflammatory IL-10.
- Liver senescence in fatty liver disease (Cao et al., PMID: 42404850): In mice with diet-induced fatty liver, apigenin reduced senescent hepatocytes by inhibiting the TGF-β/Smad pathway. It also improved liver enzymes (ALT, AST) and reduced liver fat.
- Heart protection via CD38-Sirt3 (Sumneang et al., PMID: 42451667): In rats given the chemotherapy drug cisplatin (which damages the heart), apigenin preserved heart function by modulating CD38-Sirt3 signaling and reducing oxidative stress and inflammation.
🥉 Muscle Preservation (Preclinical)
A 2026 zebrafish study (Orso et al., PMID: 42500829) found that a polyphenol blend containing apigenin prevented inflammation-induced muscle atrophy. Pre-treatment was most effective, suggesting a protective rather than restorative role.
🥉 Sleep Quality (Human Correlational Data)
Chamomile extract — which contains apigenin as its primary active compound — has been studied in small human trials for sleep and anxiety. Apigenin binds to GABA-A receptors (the same receptors targeted by benzodiazepines, but with much lower potency), producing a mild calming effect. A large cohort study found that higher dietary apigenin intake correlated with better sleep quality. However, no large RCT has tested isolated apigenin specifically for sleep.
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Zhang et al. 2026 PMID: 42119652 |
NHANES analysis n = 8,125 adults |
Apigenin is one of 5 dietary antioxidants most predictive of slower biological aging (AUC 0.93). Inverse dose-response relationship with accelerated aging. |
| Escande et al. 2013 PMID: 23172919 |
Cell culture + obese mice (Mayo Clinic / Sinclair lab) |
Apigenin is a CD38 inhibitor. Increases NAD+ levels, activates sirtuins, improves metabolic health in obese mice. |
| Ni et al. 2026 PMID: 42534541 |
Cell culture (human macrophages) |
Apigenin inhibits DOT1L → reduces H3K79me2 at IL1A → suppresses SASP in senescent macrophages. |
| Cao et al. 2026 PMID: 42404850 |
Mouse model + cell culture (fatty liver disease) |
Apigenin reduces hepatocyte senescence via TGF-β/Smad pathway inhibition. Improves liver enzymes and reduces liver fat. |
| Sumneang et al. 2026 PMID: 42451667 |
Rat study (cisplatin cardiotoxicity) |
Apigenin preserves heart function via CD38-Sirt3 signaling. Reduces oxidative stress, inflammation, and apoptosis. |
| Kramer & Johnson 2024 PMID: 38476603 |
Review (Tally Health) |
Apigenin sits at the intersection of sleep and aging. Dietary intake correlates with sleep quality. Multiple mechanisms: CD38, GABA, inflammation. |
Dosing and Safety
Recommended Protocol
| Parameter | Recommendation |
|---|---|
| Dose | 50-100 mg/day of isolated apigenin (not chamomile extract weight) |
| Timing | Evening — mild sedative/GABA effects may improve sleep onset. Take with food containing some fat to improve absorption. |
| Form | Liposomal or phytosome formulations may improve bioavailability. Standard capsules work but absorption is limited. Chamomile tea provides ~2-5 mg/cup — too low for therapeutic dosing but fine for general health. |
| Cycling | No evidence cycling is necessary. Daily use appears safe. |
Side Effects
| Side Effect | Frequency | Notes |
|---|---|---|
| Mild drowsiness | Common | Due to GABA-A receptor binding. Usually desirable if taken at bedtime. |
| Digestive upset | Uncommon | Mild nausea or stomach discomfort at high doses. Take with food to minimize. |
| Blood thinning | Theoretical | Apigenin has mild antiplatelet activity in vitro. Not clinically significant at dietary doses but caution with warfarin or other anticoagulants. |
| Hormonal effects | Theoretical | Apigenin can interact with estrogen receptors at very high concentrations. Avoid high-dose supplements during pregnancy. |
❓ Common Questions About Apigenin
What is apigenin and how does it work?
Apigenin is a natural flavonoid found in chamomile, parsley, and celery. It works primarily by inhibiting CD38 — an enzyme that destroys NAD+, a molecule essential for cellular energy and repair that declines with age. By blocking CD38, apigenin helps preserve NAD+ levels, which supports sirtuin activity (proteins that regulate aging). It also has direct anti-inflammatory and anti-senescence effects independent of CD38.
What does the evidence actually show?
The strongest evidence is epidemiological: a 2026 analysis of 8,125 U.S. adults found that higher apigenin intake was one of the top predictors of slower biological aging. In animals, apigenin consistently increases NAD+ levels, reduces senescent cells, and improves metabolic health. However, zero human randomized trials have tested whether apigenin supplements extend lifespan or healthspan. The evidence is Silver-tier — promising preclinical and population data, but no direct human longevity trials.
What’s the right dose?
The typical supplemental dose is 50-100 mg of isolated apigenin per day, taken in the evening with food. Chamomile tea only provides about 2-5 mg per cup, which is too low for therapeutic effects. Because apigenin has poor water solubility, liposomal or phytosome formulations may improve absorption. The optimal human dose for longevity is unknown — current recommendations are based on animal studies and safety data.
What are the risks and side effects?
Apigenin is very safe at dietary and supplemental doses, with a long history of consumption in chamomile tea. The most common side effect is mild drowsiness (it binds to GABA receptors, similar to a very mild version of anti-anxiety medications). At high doses, some people experience mild digestive upset. Theoretically, apigenin has mild blood-thinning and hormonal effects, but these are not clinically significant at normal supplemental doses in healthy adults.
Who should avoid it?
Pregnant women should avoid high-dose apigenin supplements due to potential hormonal effects. People taking blood thinners (warfarin, apixaban) or sedatives should consult their doctor — apigenin may amplify the effects of both. Anyone with hormone-sensitive cancers should seek medical advice, as apigenin’s interaction with estrogen receptors at high concentrations warrants caution.
The Bottom Line
Apigenin is one of the more interesting longevity supplements that most people have never heard of. It targets the same NAD+ pathway as expensive precursors like NMN, but through a more elegant mechanism: instead of pouring more NAD+ into a leaky bucket, it plugs the drain. The CD38-inhibition story is mechanistically compelling, and the 2026 NHANES data — showing apigenin as a top predictor of slower biological aging in 8,125 people — adds real-world weight.
Evidence Hierarchy (Strongest to Weakest)
- NHANES epidemiological data — n = 8,125, apigenin predicts slower biological aging (2026)
- CD38 inhibition in animals — increases NAD+, improves metabolism (2013, replicated in 2026)
- Anti-senescence effects — multiple 2026 studies in cells and mice, consistent signal
- Sleep/cognition — human correlational data + small chamomile trials, not tested with isolated apigenin
Our Verdict
🥈 Silver — Promising, wait for more data. The mechanistic story and epidemiological signal are strong enough to justify inclusion in a longevity stack, especially given the excellent safety profile and low cost. But temper expectations: no human trial has shown apigenin extends lifespan or healthspan. It’s a well-educated bet, not a sure thing.
Who This Is For
- People already taking NAD+ precursors (NMN, NR) who want to add a complementary mechanism
- Anyone interested in cellular senescence reduction without prescription senolytics
- Those with poor sleep who want to try a gentle, natural option before pharmaceuticals
Medical Disclaimer: This article is for informational and educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before starting any supplement, especially if you are pregnant, nursing, taking medications, or have a medical condition. The FDA has not evaluated these statements. Apigenin is not intended to diagnose, treat, cure, or prevent any disease.
Sources
- Zhang B, et al. “Interpretable machine learning with SHAP analysis identifies redox-modulating dietary antioxidants for predicting accelerated biological aging.” Exp Gerontol. 2026. PMID: 42119652
- Escande C, Nin V, Price NL, et al. “Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.” Diabetes. 2013. PMID: 23172919
- Kramer DJ, Johnson AA. “Apigenin: a natural molecule at the intersection of sleep and aging.” Front Nutr. 2024. PMID: 38476603
- Ni G, Ma N, Xu J. “Targeting senescence-associated secretory phenotype macrophage: apigenin inhibits DOT1L-dependent H3K79me2 at IL1A to fight SASP in senescent macrophages.” Front Mol Biosci. 2026. PMID: 42534541
- Cao L, Zhao Y. “Apigenin attenuates hepatocyte senescence in metabolic dysfunction-associated steatotic liver disease by targeting the TGF-β signaling pathway.” Cytotechnology. 2026. PMID: 42404850
- Sumneang N, et al. “Apigenin Protects Against Cisplatin-Induced Cardiotoxicity: Potential Involvement of CD38-Sirt3 Signaling in Rats.” Molecules. 2026. PMID: 42451667
- Orso G, et al. “Polyphenol dietary supplementation prevents inflammation-induced muscle atrophy in a zebrafish model.” J Sci Food Agric. 2026. PMID: 42500829
- Lauritzen KH, et al. “Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38.” Front Immunol. 2025. PMID: 39840045